Biliary Cholangitis

• CLINICAL_TRIALS trial_result · 2010-01-13
  Clinical Trial Update: Ursodiol-Methotrexate for Primary Biliary Cirrhosis [Phase 3]

  A Phase 3 clinical trial evaluating Ursodiol in combination with Methotrexate for primary biliary cholangitis has completed.

• FDA approval · 2009-11-25
  FDA Approved: URSO 250 — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for URSO 250 (ursodiol) from Allergan, Inc.

• CLINICAL_TRIALS trial_result · 2009-02-16
  Clinical Trial Update: Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis [Phase 3]

  A Phase 3 trial assessed the safety and efficacy of long-term atorvastatin treatment in patients with primary biliary cholangitis (including…

• FDA approval · 2008-12-15
  FDA Approved: URSODIOL — Original Application (Lannett Company, Inc.)

  FDA approved URSODIOL as a new generic product from Lannett Company, Inc. via an Original Application (ANDA).

• CLINICAL_TRIALS trial_result · 2007-11-01
  Clinical Trial Update: Study of Combivir for Patients With Primary Biliary Cirrhosis [Phase 2, Phase 3]

  Completed update for a study of Combivir (lamivudine/zidovudine) in patients with primary biliary cholangitis. The study comprises Phase 2 a…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.